/
KPTI
$1.99-$0.04 (-1.97%)live
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$46.0M
23M shares
52-week range
$1.80 – $10.99
2% from low
Sector
PHARMACEUTICAL PREPARATIONS
Exchange
NASDAQ
CS
Change$-67.46
Karyopharm Therapeutics Inc.
Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company focused on novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company conducts research focused on intracellular communication between the nucleus and cytoplasm and has developed small-molecule compounds that inhibit exportin 1 (XPO1), a nuclear export protein. It is focused on marketing XPOVIO (selinexor).
www.karyopharm.com- Employees
- 228
- IPO / List date
- Nov 6, 2013
- HQ
- NEWTON, MA
Held by traders on TradeandTell
No one on the platform currently holds KPTI.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 105,414 | $587.2K |
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2025-02-26 | 1-for-15reverse |
Recent trades on TradeandTell
No one on the platform has traded KPTI yet.
